Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression.
Recent insights into the molecular and cellular mechanisms underlying cancer development have revealed that immune cells functionally regulate epithelial cancer development and progression. Moreover, accumulated clinical and experimental data indicate that the outcome of an immune response toward an evolving breast neoplasm is largely determined by the type of immune response elicited. Acute tumor-directed immune responses involving cytolytic T lymphocytes appear to protect against tumor development, whereas immune responses involving chronic activation of humoral immunity, infiltration by Th2 cells, and protumor-polarized innate inflammatory cells result in the promotion of tumor development and disease progression. Herein we review this body of literature and summarize important new findings revealing the paradoxical role of innate and adaptive leukocytes as regulators of breast carcinogenesis.
DeNardo
David G
DG
Department of Pathology, University of California, San Francisco, 2340 Sutter Street, San Francisco, CA 94143, USA.
Coussens
Lisa M
LM
D001943:Breast Neoplasms / Q000276:immunology*; D018450:Disease Progression; D006801:Humans; D007107:Immune System / Q000502:physiology*; D007111:Immunity, Cellular; D007113:Immunity, Innate; D007249:Inflammation / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology
J Immunol. 1998 Jun 15;160(12):5869-73
9637498
Breast Cancer Res Treat. 1998;51(3):195-208
10068079
Curr Opin Immunol. 2002 Dec;14(6):798-802
12413532
Cancer Res. 1998 Aug 15;58(16):3491-4
9721846
Stem Cells. 1995 Sep;13(5):487-500
8528098
J Histochem Cytochem. 2001 Aug;49(8):1061-2
11457936
Nat Rev Cancer. 2002 May;2(5):373-82
12044013
J Immunol. 1997 Apr 1;158(7):3359-65
9120294
Am J Epidemiol. 2001 Sep 15;154(6):544-56
11549560
Annu Rev Immunol. 2001;19:275-90
11244038
Clin Immunol. 2004 Sep;112(3):258-67
15308119
Immunol Today. 1999 Apr;20(4):158-60
10203710
J Immunol. 2005 Oct 1;175(7):4180-3
16177055
Cancer. 1979 Dec;44(6):2083-9
92359
Nature. 2006 May 25;441(7092):431-6
16724054
Anticancer Res. 1992 Sep-Oct;12(5):1463-6
1332579
Clin Exp Rheumatol. 2007 Mar-Apr;25(2):318-28
17543163
Cancer Res. 1957 Jan;17(1):2-10
13413828
J Clin Immunol. 1983 Oct;3(4):295-315
6140268
Contrib Microbiol. 2006;13:118-37
16627962
Cancer Res. 2001 Nov 15;61(22):8298-305
11719463
Nat Med. 2004 Sep;10(9):942-9
15322536
Nat Rev Cancer. 2006 Jan;6(1):24-37
16397525
J Pathol. 2002 Mar;196(3):254-65
11857487
Int Immunol. 2001 Apr;13(4):459-63
11282985
Cancer Res. 2001 Nov 1;61(21):7889-99
11691809
J Immunol. 1999 Oct 15;163(8):4109-13
10510345
N Engl J Med. 2003 Nov 13;349(20):1968-71; author reply 1968-71
14614174
Nat Rev Cancer. 2005 Apr;5(4):263-74
15776005
Int J Cancer. 1995 Jan 17;60(2):183-9
7829213
J Immunol. 2001 Jan 1;166(1):678-89
11123353
Nature. 2002 Dec 19-26;420(6917):860-7
12490959
Liver Transpl. 2001 Nov;7(11 Suppl 1):S109-18
11689783
Immunity. 2004 Aug;21(2):137-48
15308095
Cancer Immunol Immunother. 1994 Apr;38(4):225-32
8168117
Clin Exp Immunol. 2003 Nov;134(2):169-77
14616773
Cancer Lett. 1992 Jan 10;61(2):157-64
1730139
Annu Rev Immunol. 1993;11:331-60
8476565
Trends Immunol. 2002 Nov;23(11):549-55
12401408
Curr Opin Immunol. 2007 Apr;19(2):209-16
17276050
Tumori. 1986 Feb 28;72(1):43-51
3006307
Semin Cancer Biol. 2000 Oct;10(5):351-7
11100883
J Immunol. 2001 May 1;166(9):5398-406
11313376
Oncol Rep. 1998 May-Jun;5(3):753-61
9538189
Cancer Cell. 2004 Nov;6(5):447-58
15542429
Cancer Res. 2003 Aug 1;63(15):4516-20
12907625
Cancer Cell. 2004 Oct;6(4):409-21
15488763
J Histochem Cytochem. 1996 Feb;44(2):187-91
8609376
Front Biosci. 2006;11:1360-70
16368522
Eur J Clin Invest. 2003 May;33(5):420-5
12760367
Gastric Cancer. 1999 May;2(1):26-32
11957067
Lancet. 1995 Sep 23;346(8978):796-8
7674744
Transplant Proc. 1999 Feb-Mar;31(1-2):1260-2
10083562
N Engl J Med. 2003 Apr 24;348(17):1681-91
12711744
J Immunol. 1998 Sep 15;161(6):3033-41
9743368
Clin Immunol Rev. 1981;1(1):119-214
6219849
J Clin Pathol. 2004 Jun;57(6):630-6
15166270
Eur J Cancer. 1992;28A(4-5):859-64
1524909
Science. 2006 Sep 29;313(5795):1960-4
17008531
Cancer Res. 1958 Oct;18(9):992-1003
13596939
Nat Rev Immunol. 2005 Oct;5(10):749-59
16175180
Cancer Cell. 2005 May;7(5):411-23
15894262
Int Rev Immunol. 2006 Sep-Dec;25(5-6):377-413
17169781
J Clin Endocrinol Metab. 1994 Feb;78(2):348-52
8106623
J Exp Med. 2001 Mar 19;193(6):F23-6
11257144
J Cell Biochem. 2007 Jul 1;101(4):918-26
17265430
Cancer. 1982 Apr 1;49(7):1456-64
6277465
Cancer Res. 1986 Apr;46(4 Pt 2):2121-6
3081262
Genes Dev. 1999 Jun 1;13(11):1382-97
10364156
J Clin Invest. 1998 Sep 1;102(5):938-46
9727062
Curr Opin Immunol. 2007 Apr;19(2):224-31
17303400
Cancer Lett. 2005 Dec 18;230(2):187-98
16297705
Cancer Immunol Immunother. 2004 Feb;53(2):64-72
14593498
Pathol Res Pract. 1988 Jun;183(3):356-64
3047716
Lancet. 2001 Feb 17;357(9255):539-45
11229684
Neoplasia. 1999 Nov;1(5):453-60
10933061
PLoS Med. 2005 Sep;2(9):e284
16124834
Nat Rev Cancer. 2004 Jan;4(1):71-8
14708027
J Exp Med. 2000 Jun 5;191(11):1945-56
10839809
Eur J Immunol. 2005 Aug;35(8):2452-8
15997468
J Surg Oncol. 2005 Jan 1;89(1):23-7
15612013
Cancer Immunol Immunother. 1996 Jan;42(1):1-8
8625361
Immunol Today. 1997 Jun;18(6):263-6
9190109
J Immunol. 2000 Mar 1;164(5):2782-9
10679121
J Clin Oncol. 1997 Nov;15(11):3363-7
9363867
J Immunol. 1999 Mar 1;162(5):3053-62
10072558
J Clin Oncol. 2006 Dec 1;24(34):5373-80
17135638
J Pathol. 1997 Feb;181(2):200-6
9120726
Eur J Cancer. 2004 Jul;40(11):1660-7
15251154
N Engl J Med. 2003 Aug 7;349(6):546-53
12904519
Blood. 2002 Sep 1;100(5):1728-33
12176894
J Immunol. 2000 Dec 1;165(11):6024-8
11086033
Eur Respir J. 2000 Jun;15(6):1087-93
10885428
Breast Cancer Res Treat. 1985;6(1):57-65
3902126
Nature. 2006 Jul 6;442(7098):39-44
16823444
J Neuroimmunol. 2002 Sep;130(1-2):10-21
12225884
Curr Opin Immunol. 2003 Jun;15(3):354-61
12787764
Eur Respir J Suppl. 1995 Sep;20:668s-675s
8590567
Cancer Res. 2006 Dec 1;66(23):11238-46
17114237
J Invest Dermatol. 1997 Jun;108(6):914-9
9182821
J Exp Med. 2001 Mar 19;193(6):727-40
11257139
Novartis Found Symp. 2004;256:158-68; discussion 168-72, 259-69
15027489
J Immunol. 2000 Dec 1;165(11):6015-9
11086031
Immunol Lett. 1988 Jul;18(3):181-9
3169848
J Surg Res. 1998 Apr;76(1):95-103
9695747
Cancer Immunol Immunother. 2003 Dec;52(12):715-38
12920480
Surg Gynecol Obstet. 1975 Jun;140(6):919-24
1129683
Expert Opin Biol Ther. 2004 Dec;4(12):1887-96
15571451
Ann Thorac Surg. 1995 Dec;60(6):1623-6
8787454
Cancer Cell. 2005 Mar;7(3):211-7
15766659
Cancer Res. 2002 Dec 1;62(23):7042-9
12460925
J Immunol. 1989 Feb 1;142(3):760-5
2464024